Supplier
Afterours INC
Afterours INC was paid $3.46M by Medicaid between Jan 2018 and Dec 2024, across 16 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 37% of everything it billed.
33Billing provider infoAFTEROURS INC
DENVER, CO 80224
DENVER, CO 80224
33aNPI1871626747assigned 03/13/2007
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$3.46M
24GClaims55,997
24DCodes billed16
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Colorado
Rank by total paid#39 of 645
Median peer was paid$21K
This provider vs. median168×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,197 | $356K | |
| 2019 | 7,464 | $328K | |
| 2020 | 5,795 | $311K | |
| 2021 | 14,168 | $859K | |
| 2022 | 7,974 | $547K | |
| 2023 | 7,582 | $636K | |
| 2024incomplete | 4,817 | $426K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 37% | 15,986 | 13,954 | $1.28M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 8,233 | 7,411 | $704K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 20% | 5,889 | 5,336 | $695K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 6,484 | 5,840 | $369K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.7% | 3,781 | 3,344 | $164K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.0% | 3,706 | 3,281 | $138K |
| 99050 | 1.5% | 8,429 | 7,345 | $50K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,276 | 2,104 | $32K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 380 | 328 | $20K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 158 | 142 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 350 | 322 | $5K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 77 | 72 | $3K |
4 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 31 | $421.72 |
| 81002 | <1% | 135 | $276.18 | |
| 81025 | <1% | 14 | $132.71 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 68 | $93.84 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREHM, CHRISTOPHER (PRESIDENT)